These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 25470092

  • 41. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Hazell P.
    Australas Psychiatry; 2010 Dec; 18(6):556-9. PubMed ID: 21117844
    [Abstract] [Full Text] [Related]

  • 42. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
    Babcock T, Ornstein CS.
    Postgrad Med; 2009 May; 121(3):73-82. PubMed ID: 19491543
    [Abstract] [Full Text] [Related]

  • 43. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 44. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms.
    Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT.
    Am J Psychiatry; 1995 Dec; 152(12):1793-9. PubMed ID: 8526248
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.
    Neuropsychiatr; 2007 Dec; 21(3):187-206. PubMed ID: 17915180
    [Abstract] [Full Text] [Related]

  • 48. Co-morbidity of bipolar disorder in children and adolescents with attention deficit/hyperactivity disorder (ADHD) in an outpatient Turkish sample.
    Lus G, Mukaddes NM.
    World J Biol Psychiatry; 2009 Dec; 10(4 Pt 2):488-94. PubMed ID: 19401947
    [Abstract] [Full Text] [Related]

  • 49. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP, Bettinger TL, Patel NC, Crismon ML.
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [Abstract] [Full Text] [Related]

  • 50. Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study.
    McIntyre RS, Jerrell JM.
    J Clin Psychiatry; 2009 Feb; 70(2):240-6. PubMed ID: 19192465
    [Abstract] [Full Text] [Related]

  • 51. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
    Merrill RM, Thygerson SM, Palmer CA.
    Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC, Bisgaard C.
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [Abstract] [Full Text] [Related]

  • 54. Attention deficit hyperactivity disorder in adolescent mania.
    West SA, McElroy SL, Strakowski SM, Keck PE, McConville BJ.
    Am J Psychiatry; 1995 Feb; 152(2):271-3. PubMed ID: 7840364
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders.
    Pouchon A, Nasserdine R, Dondé C, Bertrand A, Polosan M, Bioulac S.
    Expert Opin Pharmacother; 2023 Feb; 24(13):1497-1509. PubMed ID: 37300473
    [Abstract] [Full Text] [Related]

  • 58. Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset.
    DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM.
    Bipolar Disord; 2001 Apr; 3(2):53-7. PubMed ID: 11333062
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
    McAfee AT, Holdridge KC, Johannes CB, Hornbuckle K, Walker AM.
    Curr Drug Saf; 2008 May; 3(2):123-31. PubMed ID: 18690990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.